bpc-157 human clinical evidence randomized trial tendon healing and the Difference Between an Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — BPC-157 Peptides: Research, Evidence &

Full-length thymosin beta-4 (T4) is a 43-amino acid endogenous peptide that functions as the primary G-actin sequestering protein in mammalian cells and maintaining the cellular pool of polymerisation-competent actin monomers and regulating cytoskeletal dynamics through its central LKKTETQ actin-binding motif

doi: 10.1038/nrm2639

Helps Prevent or Treat Diabetic Neuropathy: Theres evidence showing that vitamin B12 supplements may improve symptoms among people with diabetic neuropathy, nerve damage thats associated with diabetes

A phase 1 clinical trial was conducted to evaluate the safety and pharmacokinetics of BPC 157 compared to placebo in healthy volunteers, with results reportedly submitted to ClinicalTrials.gov on May 23, 2016